My understanding of what happened in the second phase:
We all know that there is a "placebo effect" ... But, in my opinion, this effect is more pronounced in more mild diseases.
Therefore, in the trials of CLI, the placebo effect is less likely. In addition, we saw that in the american group this effect wasn't. The company must understand why. I hope that there will be more explanations..
Market Data 
Markets 
